Poniard Pharmaceuticals Inc

Permanently closed
Call
Website
750 Battery St Ste 330
San Francisco, CA 94111
+1 (650) 583-3774
http://poniard.com
Dedicated to the development and commercialization of oncology products, Poniard Pharmaceuticals is a cancer therapeutics development company. The company s main focus is on the development of picoplatin, a next-generation platinum therapy with improved safety features that is designed to overcome platinum-based chemoresistance. Poniard Pharmaceuticals is studying picoplatin in a Phase II trial in patients with small cell lung cancer. The company is collaborating with Scripps Florida, a division of the Scripps Florida Research Institute, on the discovery of novel, small-molecule, multi-targeted, protein kinase inhibitors as therapeutic agents, including cancer treatments. Poniard Pharmaceuticals maintains its corporate headquarters in South San Francisco, Calif.

Also at this address

Own this business?
See a problem?

You might also like

Pharmacyclics
Drugs acting on the respiratory system, Drugs and drug proprietaries, Internal medicine practitioners

Pharmacyclics

2
"I would like to say this company is quite impressive. My son is a rising high school senior in Georgia was in the area to tour Stanford wanted to see a company where bio-medical sciences were..."
Vivus
Perfumes and colognes, Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Vivus

VIVUS is a pharmaceutical company focused on the development and commercialization of new therapeutic products addressing obesity and sexual health, having its facilities in Mountain View, Calif. VIVUS has four products that are positioned to enter Phase 3 clinical trials, and one product that has completed Phase 3 evaluation, for which a new drug application has been submitted to the Food and Drug Administration. The pipeline includes QnexaTM, for which a Phase 2 study has been completed for the treatment of obesity, ALISTATM, for which a Phase 2B program is ongoing for the treatment of female sexual arousal disorder. Other products under development include Testosterone MDTS, for which a Phase 2 program has been completed for the treatment of hypoactive sexual desire disorder, and EvamistTM, for which a Phase 3 program has been completed for the treatment of menopausal symptoms. VIVUS has also developed and is marketing MUSE, a treatment for erectile dysfunction.
Internal medicine practitioners, Drugs acting on the respiratory system

Structure Therapeutics Inc

Structure Therapeutics Inc is a biotechnology company based in South San Francisco, CA, focused on innovative therapeutic approaches. The company is dedicated to advancing its pipeline of drug candidates aimed at addressing unmet medical needs. With a team of experienced professionals, Structure Therapeutics emphasizes collaboration and cutting-edge research in the development of its therapies. Their commitment to scientific excellence drives their mission to improve patient outcomes through novel treatments. Generated from the website
United States›California›San Francisco›Poniard Pharmaceuticals Inc

Partial Data by Infogroup (c) 2024. All rights reserved.